FibroGen Obtains $145,800,000 New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    409 Illinois St. San Francisco, CA 94158 USA
  • Company Description
    FibroGen (NASDAQ: FGEN) is focused on the discovery, development, and commercialization of new treatments for fibrosis, anemia, conditions associated with tissue damage or injury, and cancer based on our scientific leadership in tissue fibrosis and HIF biology.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy